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Acute exposure to acrylamide (ACR), a type-2 alkene, may lead to a ataxia, skeletal muscles weakness 
and numbness of the extremities in human and laboratory animals. In the present manuscript, ACR 
acute neurotoxicity has been characterized in adult zebrafish, a vertebrate model increasingly used 
in human neuropharmacology and toxicology research. At behavioral level, ACR-treated animals 
exhibited “depression-like” phenotype comorbid with anxiety behavior. At transcriptional level, ACR 
induced down-regulation of regeneration-associated genes and up-regulation of oligodendrocytes and 
reactive astrocytes markers, altering also the expression of genes involved in the presynaptic vesicle 
cycling. ACR induced also significant changes in zebrafish brain proteome and formed adducts with 
selected cysteine residues of specific proteins, some of them essential for the presynaptic function. 
Finally, the metabolomics analysis shows a depletion in the monoamine neurotransmitters, consistent 
with the comorbid depression and anxiety disorder, in the brain of the exposed fish.
Acrylamide (ACR) is a water-soluble alkene widely used in the paper and textile industries, as flocculant in the 
wastewater treatment and municipal drinking water, as soil conditioner, as chemical grout in tunnels, sewers and 
wells, in ore processing, and in cosmetics1,2. Reports of ACR poisoning after occupational or accidental exposure 
to ACR indicated major symptoms related to polyneuropathy, including lethargy, ataxia, skeletal muscle weakness 
and numbness of the extremities3–5. Although early studies suggested that ACR neurotoxicity was associated with 
central-peripheral distal axonopathy6, it is currently well-established that the molecular initiating event (MIE) 
of ACR neurotoxicity is the disruption of presynaptic vesicle cycling by selectively forming adducts with thiolate 
sites located on proteins specifically involved in vesicle docking (synaptotagmin, synaptophysin, and syntaxin), 
vesicle priming (complexin-2), SNARE core dissolution (N-ethylmaleimide sensitive factor), endocytosis (clath-
rin), neurotransmitter re-uptake (membrane dopamine transporter) and vesicular storage (vesicular monoamine 
transporter) at the nerve terminals7. Consistently with this adverse effect of ACR on the presynaptic terminals 
function, a decrease in the monoamine neurotransmitters serotonin, norepinephrine and dopamine content in 
rat brain has been reported8,9. As monoamine depletion is believed to result in depression and anxiety10, the 
potential of ACR to induce these psychological disorders should be conveniently addressed.
Zebrafish (Danio rerio) is a vertebrate model increasingly used in biomedical research, including neurotoxi-
cology studies11–16, as this animal species exhibits a similar overall nervous system organization to humans and 
similar neurotransmitter systems, including glutaminergic, cholinergic, serotonergic, dopaminergic, adrenergic, 
GABAergic, and histaminergic11,15,17. Recently we characterized the ACR acute neurotoxicity in zebrafish larvae 
by exposing 5 days post-fertilization (dpf) animals to 1 mM ACR for 3 days15. The reported results suggest that the 
adverse outcome pathways behind the ACR acute neurotoxicity in zebrafish larvae are similar to those described 
in humans and mammalian models15. However, adult zebrafish is more feasible than larvae for modeling com-
plex brain disorders due to their well-developed central nervous system (CNS) and more complex behaviors18,19. 
Moreover, as zebrafish are a less sentient species, the use of adult zebrafish for modeling brain disorders fully 
meets the 3Rs principles (Replacement, Reduction and Refinement)18. Adult zebrafish have been used to model 
affective disorders, including stress-related, anxiety spectrum, depression, post-traumatic and phobic disorders, 
and multiple behavioral paradigms, resembling well-established rodent tests, have been developed18,20.
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In this study, we characterized ACR acute neurotoxicity in adult zebrafish by waterborne exposure of the 
animals to 0.75 mM ACR for 3 days. Behavioral effects have been thoroughly analyzed, and changes in the tran-
scriptomic, proteomic and neurochemical profiles in the brain of the exposed fish have been determined. Finally, 
the presence of ACR adducts in selected cysteine residues of specific brain proteins has been analyzed.
Results and Discussion
Systemic toxicity. The preferred concentration to be used in this study should be high enough to max-
imize the chance of detecting a neurotoxic effect, but not so high to induce systemic toxicity, an important 
confounding factor21. In mammalian toxicology this concentration at the threshold of the systemic toxicity is 
known as Maximum Tolerated Dose (MTD), and this concept has been translated to fish toxicology as Maximum 
Tolerated Concentration (MTC)22. Therefore, a total of 123 adult zebrafish were exposed for 72 h to different 
ACR concentrations and mortality was recorded. Whereas the 50% lethal concentration (72h-LC50) was esti-
mated at 1.22 ± 0.02 mM ACR, the non-observed effect concentration (NOEC) for lethality was 0,75 mM ACR 
(Supplemental Fig. S1).
Behavioral effects. Results of the Novel Tank Test (NTT) with control and ACR-treated fish are shown in 
Figs 1 and 2. First of all, ACR induced hypolocomotion in the NTT, with a significant decrease in the total dis-
tance travelled (p < 0.001). The reduction observed in the distance travelled was more dramatic in the top of the 
tank than in the bottom (Supplementary Video S1). Moreover, ACR treatment increased the latency to top, tran-
sitions to top and time in top (p < 0.001). Whereas ACR treatment increased the latency to top, transitions to top 
and time in top were significantly reduced. Representative traces generated by Ethovision XT 13.0 software clearly 
support the dramatic effect of ACR on the top swimming (Fig. 1). The time-course analysis of the distance moved 
in the top and the time in top shows that control fish progressively increase the activity in the top of the tank with 
time, a typical habituation response to a novel environment23,24. In contrast, ACR-treated fish exhibited a very 
low activity in the top throughout the 6 min period. ACR also altered the mobility state duration of the fish, sig-
nificantly decreasing the high-mobility duration (p < 0.001) and increasing the immobility duration (p < 0.001). 
ACR significantly increased also the number of freezing bouts (Supplementary Video S2; p < 0.01), the freezing 
duration (p < 0.01) and the erratic movements duration (p < 0.05). Moreover, ACR increased the transitions from 
freezing to normal swimming, from freezing to erratic and from normal swimming to freezing. Ethogram-based 
analyses provided another intuitive way to assess the changes in activity observed in ACR-treated fish (Fig. 2). 
Finally, ACR evoked a clear droopy tail phenotype (Supplementary Video S3), commonly associated with neuro-
logical deficits, akinesia and global hypolocomotion, in 21% of the treated fish. The prevalence of this phenotype 
in the control group was 0%.
Results of the Open Field Test (OFT) performed on control and ACR-treated zebrafish are shown in Fig. 3. 
Similarly to the NTT results, ACR induced hypolocomotion in zebrafish, with a significant reduction (p < 0.001) 
in the total distance moved in the tank during the 6 min period of the test. However, when the distribution of the 
locomotor activity between the center and the periphery of the tank was analyzed, a negative thigmotaxis was 
found in the ACR-treated fish. Thus, whereas the distance and time in the periphery were significantly reduced 
(p < 0.001), a concomitant increase was found both in the distance moved and the time spent in this central zone 
(p < 0.001). Representative traces generated by Ethovision XT13.0 software clearly support the negative thigmo-
taxis induced by ACR (Fig. 3). Changes observed in the mobility state duration were consistent with those found 
in the NTT, with a significant decrease in the high mobility duration (p < 0.001) and an increase in the immobility 
duration (p < 0.05). When parameters related with changes in direction of the movement were analyzed, a signif-
icant increase in the absolute meandering, turn angle and angular velocity (p < 0.05) were found in ACR-treated 
fish. Moreover, a tight circling behavior25, with repetitive swimming in circles of two body-lengths (about 5 cm) 
in diameter was identified in the ACR-treated group (Supplementary Video S4), with a significant increase in the 
prevalence of this behavior (p < 0.05) and in the number of animals exhibiting high rotation (p < 0.01), defined 
as 5 or more full rotations per trial26. No lateralization in the direction of rotations (p > 0.05) was found in any 
experimental group.
Results from the shoaling test with control and ACR-treated fish are shown in Fig. 4a. ACR significantly 
increases social cohesion, as indicated by the significant decrease in the inter-fish distance (p < 0.01) and farthest 
distance (p < 0.05).
When the whole-body cortisol levels were analyzed, a significant increase was found in those animals exposed 
to ACR [Fig. 4b; 0.226 ± 0.041 vs 0.802 ± 0.135 ng/g for control (n = 16) and ACR-treated (n = 14) zebraf-
ish, respectively; p < 0.0005]. Finally, a consistent darkening of the zebrafish skin coloration was found in the 
ACR-exposed group [Fig. 4b; χ2 (1) = 17.298, p < 0.001].
ACR neurotoxicity in humans and mammalian animal models is characterized by an impairment in the motor 
function7. Hypolocomotion observed in the NTT and OFT in the ACR-treated zebrafish in this study is consistent 
with the reduction in the basal locomotor activity found in the zebrafish model developed in larvae15. In zebraf-
ish, hypolocomotion and droopy tail phenotype are indicative of motor retardation, a common motor symptom 
of clinical depression25,26. Moreover, elevated corticosteroids are also commonly seen in depressed patients and 
in animal experimental models of depression27. Thus, hypolocomotion, droopy tail and the significant increase 
in the whole-body cortisol levels found in the ACR-exposed animals are all hallmarks of a depression-like phe-
notype. Finally, the changes in the skin coloration presented by the ACR-exposed zebrafish are similar to the 
long-term skin darkening reported in zebrafish exposed to the catecholamine-depleting drug reserpine28, an 
additional data supporting the induction of a depression-like phenotype by ACR exposure. However, not all 
the clinical symptoms found in the ACR-exposed fish are consistent with a depressive disorder. Thus, some 
of the most significant behavioral changes exhibited by ACR-treated fish in the NTT (increase in the bottom 
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dwelling behavior, the number of freezing bouts, freezing duration and erratic movements) and in the shoaling 
test (increase observed in the shoal cohesion) are typical responses to anxiogenic stimuli in adult zebrafish29–31.
Although depression and anxiety have historically been seen as distinct conditions, the two disorders are fre-
quently comorbid, with approximately two thirds of patients with depression have a comorbid anxiety disorder32. 
The behavioral results presented here demonstrate that acute exposure to ACR induces depression-like comorbid 
with anxiety in adult zebrafish.
Figure 1. Behavioral effects of 3 days exposure to 0.75 mM acrylamide (ACR) on zebrafish tested in the novel 
tank. (a) Behavioral parameters assessed in standard 6-min novel tank test (NTT), as well as a cartoon of the 
experimental tank divided into two equal virtual zones, top and bottom and representative traces of control and 
ACR-treated zebrafish.
www.nature.com/scientificreports/
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Effects on transcriptional level. In order to better characterize the ACR targets in the adult zebrafish 
CNS, the expression of genes involved in different functions in neurons and glia was analyzed (Fig. 5). First of 
all, at the axonal level, a significant down-regulation was found in the expression of the regeneration-associated 
genes (RAGs) growth-associated protein GAP-43 (gap43) and α1 tubulin (tuba1b). The expression of myelin 
basic protein (mbp) and glial fibrillary basic protein (gfap), expressed in oligodendrocytes and reactive astrocytes, 
was found up-regulated. Moreover, ACR induced changes in the expression of genes involved in the synaptic 
vesicle cycling. Thus, whereas the expression of nsfa and syt1a were found up-regulated, syn2a expression was 
down-regulated. Finally, the expression of the immediate early gene c-fos was down-regulated.
In teleosts, including zebrafish, the success of CNS regeneration may be determined, at least in part, by the 
induction of RAGs33. The absence of this regenerative response in ACR-treated zebrafish, as indicated by the 
significant down-regulation in the expression of gap43 and tuba1b in this study and by the absence of induction 
of these genes in zebrafish larvae15, is consistent with the absence of severe axonal damage reported in acute 
ACR exposures7. Moreover, the up-regulation of gfap found in the brain of ACR-treated zebrafish in this study 
is consistent with the increase in the GFAP immunoreactivity reported in the brain of rats and mice exposed 
to ACR34,35. However, this effect on gfap expression was not found in ACR-treated zebrafish larvae15, probably 
Figure 2. Behavioral effects of 3 days exposure to 0.75 mM acrylamide (ACR) on zebrafish: erratic movements 
and freezing bouts. Erratic movements, number and duration (s) of freezing bouts manual and ethograms 
allowing to visualize the occurrence of these behaviors and the transitions between them, with the diameter 
of each circle reflecting the frequency of the behavioral activity, and the width and direction of each arrow 
representing the frequency of the transitions between behaviors. Data reported as mean ± SEM (n = 23–24), 
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t-test). Data from 3 independent experiments.
www.nature.com/scientificreports/
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reflecting differences in the regulation of this gene with the developmental stage. The up-regulation found in 
the synaptic vesicle cycling genes nsfa and syt1a in the brain of ACR-treated zebrafish paralleled the effect of 
this compound in zebrafish larvae15. The finding of a similar effect of ACR on the expression of nsfa and syt1a 
in zebrafish larvae (immature central and peripheral nervous system), and the adult brain (mature CNS), makes 
these two genes good candidates as ACR neurotoxicity markers. Finally, c-fos expression is a marker of neuronal 
activation in rodents and zebrafish, and has been shown to correlate with environmentally or pharmacologically 
induced anxiety36. Thus, the down-regulation of c-fos found in this study in response to ACR strongly supports 
that the behavioral effects observed in ACR-treated zebrafish are not related to an increase in the anxiety levels.
Figure 3. Behavioral effects of 3 days exposure to 0.75 mM acrylamide in the open field. Behavioral parameters 
assessed in standard open field test (OFT), as well as representative traces of control and ACR-treated zebrafish, 
showing the two virtual zones, center and periphery, in the arena.
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Effects of ACR on the adult fish brain proteome. The current view is that ACR induce synaptotoxicity 
in mammals and that the MIE is the formation of ACR-adducts in cysteine residues involved in the synaptic ves-
icle cycle at the nerve terminal, resulting in altered function of the modified proteins and, finally, in altered neu-
rotransmission7. In order to determine if ACR altered the expression of proteins involved in synaptic vesicle cycle 
in the nerve terminal of adult zebrafish brain, the proteome of control and exposed animals was compared. Five 
pools of 3 brains from either ACR-treated or untreated groups were proteolyzed and analyzed by capillary chro-
matography and tandem mass spectrometry (μLC-MS/MS). A total of 4,515 proteins were identified in at least 3 
of the samples and with at least 2 different tryptic peptides (Supplementary Dataset 1). Following the ACR treat-
ment the intensities of 57 proteins were down-regulated while the intensities of 65 proteins were up-regulated 
(Fig. 6a and Supplementary Dataset 2).
One interesting protein up-regulated after ACR treatment was Adhesion G protein-coupled receptor 
L3.1 (Adgrl3.1), involved in ADHD and addiction in humans37. This protein has been suggested to modulate 
Figure 4. Effects of 3 days exposure to 0.75 mM acrylamide on the shoaling test, cortisol levels and skin 
coloration. (a) Behavioral parameters of zebrafish shoaling behavior in control and ACR-treated zebrafish. 
Data reported as mean ± SEM (n = 23–25 for OFT and n = 16–18 for shoaling test), *p < 0.05, **p < 0.01, 
***p < 0.001 (Student’s t-test). Data from 3 independent experiments. (b) Whole-body cortisol levels and 
skin coloration in control (n = 16–18) and ACR-treated (n = 14–16) adult zebrafish. Data from 3 independent 
experiments.
www.nature.com/scientificreports/
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dopaminergic neuron formation and locomotor activity during zebrafish development37. Moreover, loss of 
function of Adgrl3.1 causes an hyperactive motor phenotype in both zebrafish37 and mice38, and this phenotype 
can be rescued by ADHD treatment drugs37. Granulin a, the homologue of human GRN based in syntenia39, 
and Synuclein gamma b, were also up-regulated in the brain of ACR-treated zebrafish. Up-regulation of pro-
granulin, the precursor of Granulin a, seems to be part of the inflammatory response after acute or chronic 
insults in the CNS in mammalian models40. Synuclein gamma b up-regulation, hypolocomotion and an increase 
in freezing bouts and freezing duration in the NTT, some of the effects of acute exposure to ACR identified 
in this study, were also found in a model of Parkinson’s disease in zebrafish induced by 1-metyl-4-phenyl-1,
2,3,6-tetrahydropyridine (MPTP)41. Finally, the peptide Galanin was also found up-regulated in the brain of 
ACR-treated animals. Hypolocomotion and depression-like behavior have been also described in mice overex-
pressing galanin42. Similar to the transcriptomic results, proteomic analysis found down-regulation of Tubulin 
alpha chain and Synapsin IIa. Down-regulation was also found in another two proteins involved in neurotrans-
mission, Huntingtin interacting protein 1 (Hip1) and Synaptosomal-associated protein 47 (Snap47). Whereas 
Hip1 plays a role in clathrin-mediated endocytosis and trafficking, Snap47 is involved in regulating AMPA recep-
tor trafficking in the CNS in an NMDA-dependent manner43,44.
Sulfhydryl thiolate state of cysteine residues are the preferred target of for the covalent interactions of ACR7. 
At physiological conditions, sulfhydryl thiolate groups can be found in cysteine-centered catalytic triads, often 
located within the active sites of many critical presynaptic terminal enzymes. ACR adducts formed with the 
cysteine located at the catalytic triads will have substantial implications for protein function and subsequent pre-
synaptic toxicity31. When the presence of covalent acrylamide adducts was analyzed in control and ACR-exposed 
larvae, 191 proteins were detected with modifications on specific cysteine residues in at least 3 of the ACR-pools 
(Fig. 6b and Supplementary Dataset 3). Fifty-three of these modified proteins were also modified in the larva stage 
as was shown before, suggesting developmental conservation of the target proteins (Supplementary Dataset 4). 
Interestingly, some proteins specifically involved in the synaptic vesicle cycle, were modified by ACR. Thus, ACR 
formed adducts at Cyst91 and Cyst106 of Complexin 2, a cytosolic protein that positively regulates a late step in 
synaptic vesicle exocytosis45. ACR adducts were also found at Cyst155 and Cyst417 of Synapsin I and IIb, respec-
tively. Synapsins are phosphoproteins binding synaptic vesicles to components of the cytoskeleton which prevents 
them from migrating to the presynaptic membrane and release their neurotransmitters45. Synaptotagmin VIIa, 
calcium sensor playing a crucial role in neurotransmitter release, was found altered by ACR at Cyst 413, 431 and 
532. Finally, ACR formed adducts at Cyst142 of vesicle-associated membrane protein (VAMP). Whereas VAMP/
synaptobrevin forms together with SNAP-25 and syntaxin the presynaptic SNARE complex, VAPA interacts with 
VAMP and is necessary for vesicular neurotransmission45. Some protein related to the dendritic spines, as Arp2/3 
complex 34 kDa subunit, Debrin 1 and Striatin calmodulin-binding protein, were also modified by ACR.
Other enriched groups of proteins that were found to be modified by ACR adducts include processes of cell 
redox homeostasis (Thioredoxin, Thioredoxin 2, Peroxiredoxin 2, Peroxiredoxin 6), as well as proteins involved 
in biosynthesis of amino acids and glycolysis/gluconeogenesis (Fructose-bisphosphate aldolase, Glutamine 
synthetase, Aspartate aminotransferase, Phosphoglycerate kinase, Phosphoglycerate mutase). Interestingly, 
many of the synaptosomal proteins known to be modified by ACR in rat brain46, including Complexin 2, 
Synaptotagmin, Secernin 1, Ubiquitin carboxyterminal hydrolase isozyme L1, Glutamine synthetase 1, Cofilin-1, 
Voltage-dependent anion-selective channel protein 3, Aspartate aminotransferase, and Ubiquinol-cytochrome c 
reductase complex, were also found modified in the zebrafish brain.
The expression levels of most proteins were not changed as a result of the modification, with the exception 
of COX17 cytochrome c oxidase assembly homolog, Glycoprotein M6Bb, Hydroxypyruvate isomerase, Tubulin 
alpha chain, Synapsin II and Voltage-dependent anion channel 3 (Fragment). It is very interesting that both 
Figure 5. Expression of selected transcripts related with axonal damage, synaptic vesicle cycling and 
neurotoxicity in the brain of adult zebrafish exposed to 0.75 mM acrylamide (ACR) for 3 days. Results are 
plotted as log2 ΔΔCt, in order to see both the up regulation and the down regulation. *p < 0.05 (Student’s 
t-test). Data from 3 independent experiments (n = 14–17).
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Synapsin II and Tubulin alpha chain, significantly down-regulated at the transcriptome and the proteome levels, 
were found to be modified by the ACR both in the brain as well as in the whole-larvae samples.
Changes in the neurochemical profile. In order to assess if ACR altered neurotransmission in adult fish 
brain, thirty-eight neurochemicals, including neurotransmitters, precursors, metabolites and neuromodulators, 
were analyzed in individual brains from the control (n = 12) and ACR-treated (n = 12) groups, from 3 independ-
ent experiments. Prior to the collection of the brain samples, behavioral analysis of each animal was performed 
through the NTT and OFT, in order to be able to associate to each fish both a neurochemical and neurobehavioral 
profile. Thirty-six of the neurochemicals analyzed in the brain of fish from both experimental groups were above 
the limit of quantification (Supplementary Table S2), and the level of seventeen of them was significantly altered 
by the ACR-treatment.
A PLS-DA using both the 36 neurochemical levels (in ng/mg of brain w.w.) and 20 selected behavioral param-
eters correctly associated the 24 samples either to the ACR-treated or to the control groups for the two extracted 
components, except for single treated sample in component 1, using the 42.3% of the total variance of the param-
eters (Mfold test, Fig. 7a). Twenty-five out of the fifty-six parameters included in the analysis showed Variables 
Important for Projection (VIPs) scores above 1, twelve neurochemical levels and thirteen behavioral parame-
ters (Figs 7b and S2). Most VIPs were associated to control samples (green areas in Fig. 7), indicating a reduc-
tion of the parameters’ values (either concentrations or frequencies) in ACR-treated animals. Most important 
neurotransmitters (acetylcholine, dopamine, serotonin, norepinephrine, glutamate) showed this association to 
Figure 6. Effects of acrylamide exposure on the adult zebrafish brain proteome. (a) Unsupervised heat 
map of the differential proteins. Hierarchical euclidean clustering was performed on the intensities of the 
differential proteins after Z-score normalization. It was done using the Perseus software. Left panel represents 
the down-regulated proteins and the right panel the up-regulated proteins following the ACR treatment. (b) 
ACR-modified cysteine residues. Left panel represent the expression levels of the 191 proteins containing ACR-
modified cysteine residues, and the right panel the Log-2 intensities of the peptides with ACR –adducts in 
cysteine residues. CN: control pool (n = 5 pools; 3 brains each); ACR: pool ACR (n = 5 pools; 3 brains each).
www.nature.com/scientificreports/
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non-treated samples, as did different behavioral parameters linked to locomotor activity (distance, high mobility) 
or exploratory behavior (time and frequency in top). Conversely, behavioral parameters related with an anxio-
genic response (freezing behavior and immobility) were associated to ACR-treated samples (Fig. 7, red areas), as 
well as the dopamine precursor phenylalanine and the serotonin metabolite 5-HIAA.
When the main neurotransmitter systems were analyzed with more detail (Fig. 7c), a significant effect of ACR 
on cholinergic, serotonergic and dopaminergic systems was found. The effect of ACR on dopaminergic system 
is especially dramatic, with a significant increase in the levels of the precursors phenylalanine and tyrosine, and 
a concomitant significant decrease in the levels of the neurotransmitters dopamine and norepinephrine. A sim-
ilar reduction in the content of dopamine and norepinephrine has been described in the brain of rats exposed 
Figure 7. Changes in the profile of neurochemicals in the brain of adult zebrafish control and exposed to 
0.75 mM acrylamide (ACR) for 3 days. (a,b) Results from the PLS-DA analysis. (a) Bi-plot of sample scores 
(circles) and parameter loadings (in black characters, only VIPs); green and red symbols correspond to control 
and acrylamide-treated samples. (b) List of parameters showing VIPs scores above 1. Green and red shadows 
indicate parameters associated to control and treated groups, respectively. Short (key) and complete names 
are indicated. (c) Changes in the profile of the main neurotransmitter systems in zebrafish brains exposed for 
3 days to 0.75 mM ACR. Values are represented as log2 of fold change to control; green and purple columns 
correspond to decreased and increased levels of neurochemicals respect to the controls. Statistical analysis 
performed using Student’s t-test, *p < 0.05. Data from 2 independent (n = 12 per group).
www.nature.com/scientificreports/
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to ACR8, and the depletion of these neurotransmitters for some neuroactive chemicals, as reserpine, have been 
related with symptoms of CNS depression, including sedative or depression-like action8,27. Moreover, when the 
levels of dopamine and norepinephrine were decreased in adult zebrafish after injection of MPTP and 6-OHDA, 
a phenotype characterized by hypolocomotion and increased turn angle was reported47. All these data suggest 
that the decrease in the dopamine and norepinephrine content found in the brain of ACR-treated fish might be 
involved in the hypolocomotion and the angular behavior exhibited by these animals. Interestingly, in addition to 
the hyperactivity, dorsal striatum of nice null for Adgrl3 gene contains high levels of dopamine and serotonin37, 
so the observed increase in the levels of this protein in ACR-treated proteins might be involved in the observed 
decrease in the levels of both neurotransmitters.
Moreover, tight circling behavior has been reported after zebrafish exposure to some antagonist of the 
N-methyl-D-aspartate (NMDA) receptors, including ketamine and phencyclidine26,48,49. Consequently, the tight 
circling phenotype presented by ACR-treated fish might be related with the significant decrease in glutamate and 
aspartate, natural agonist of the NMDA- receptors, exhibited by these animals.
When the changes in the neurochemical profile in the brain of adult zebrafish exposed for 3 days to 0.75 mM 
ACR were compared with the changes reported in 8 dpf zebrafish larvae exposed for 3 days to 1.0 mM ACR15, 
important differences became evident. Thus, whereas the levels of the neurotransmitters acetylcholine and nor-
epinephrine were significantly reduced by ACR-treatment in adult brain, they were significantly increased in the 
whole-larvae. Moreover, whereas the levels of glutamate, aspartate and serotonin were also significantly reduced 
in adult zebrafish brain exposed to ACR, these neurotransmitters remained unchanged in whole-larvae. The 
observed differences between adult brain and whole-larvae are not surprising considering that each type of sam-
ple provides a different picture of the problem. Whereas the former provides information on changes in the a 
fully mature CNS, the latter integrates information not only at central and peripheral nervous systems still under 
development, but also from other non-neural tissue.
Conclusions
ACR acute neurotoxicity has been characterized in adult zebrafish. This neurotoxicant not only changes the tran-
scriptomic and proteomic profiles of the brain, but also forms adducts with selected cysteine residues of spe-
cific proteins of the brain, including relevant components of the presynaptic vesicle cycling. The depression-like 
behavior and the concomitant depletion in the monoamine neurotransmitters found in the ACR-treated ani-
mals suggest for the fist time that the hypolocomotion commonly observed after ACR exposure might represent 
a motor retardation-like phenotype associated to the depletion of monoamine neurotransmitters in the brain. 
Moreover, the fact that the overall effects of ACR in adult zebrafish are similar to those described in the larvae 
support the suitability of the zebrafish ACR acute neurotoxicity recently developed in larvae for screening of 
molecules with therapeutic value to treat this toxic neuropathy.
Methods
Animals and housing. A total of 302 adult wild-type zebrafish were obtained from Piscicultura Superior 
(Barcelona, Spain) and maintained in fish water [reverse-osmosis purified water containing 90 µg/ml of Instant 
Ocean (Aquarium Systems, Sarrebourg, France) and 0.58 mM CaSO4 · 2H2O] at 28 ± 1° in the Research and 
Development Centre of the Spanish Research Council (CID-CSIC) facilities under standard conditions. 
Aquarium lighting (650–850 lx) was provided by aquarium-mounted fluorescent light with a 12 L:12D photoper-
iod. They were fed twice a day with flake food (TetraMin, Tetra, Germany). All procedures were approved by the 
Institutional Animal Care and Use Committees at the CID-CSIC and conducted in accordance with the institu-
tional guidelines under a license from the local government (agreement number 9027).
Experimental procedure. ACR (CAS#79–06–1, ≥99% purity) was purchased from Sigma-Aldrich (A9099; 
St. Louis, MO). On the day of the experiment, a fresh stock solution (500 mM ACR) was prepared directly in fish 
water, and then exposure solutions were prepared by diluting the stock in fish water. Adult zebrafish (≈50:50 
male:female ratio) were randomly selected from the CID-CSIC facilities and exposed for 72 h to 0.65–3.0 mM 
ACR (Sigma-Aldrich, St. Louis, MO), at 28.5 °C and a 12 L:12D photoperiod. Control fish were maintained in fish 
water under identical conditions. Although ACR concentrations remain stable in our experimental conditions 
for more than 5 days15, experimental solutions were renewed daily, 30 min after feeding. After exposure, some fish 
were randomly selected for behavioral testing and further whole-body cortisol and metabolomics analyses, while 
others were selected for transcriptomic and proteomic analyses. For sample collection, fish were euthanized by 
inducing hypothermic shock in ice-chilled water (2° to 4 °C), and the brains and fish whole-body were immedi-
ately collected and stored at −80 °C for further analyses.
Concentration-response analysis for lethality. LC50 was obtained by fitting responses relative to con-
trol to the nonlinear allosteric decay regression model (see Supplementary Methods for additional details).
Behavioral testing. All testing was performed in an isolated behavioral room at 27–28 °C. Animals (≈50:50 
male:female ratio) were brought to the behavioral room one hour before testing began, to acclimate to the envi-
ronment, and then, behavioral testing was performed between 10:00 and 13:00 h. All fish used in this study were 
experimentally naïve and all behavioral testing was performed in a blind manner, with observers unaware of 
the experimental group. Behavioral tests used in the present study include the novel tank test (NTT), open field 
test (OFT), and shoaling test. In order to reduce the number of animals needed for this study, NTT and OFT 
were performed following a test battery approach, and after that these animals were euthanized and brain were 
immediately collected and stored at −80 °C for for metabolomics analysis. The suitability of using test batteries of 
behavioral assays in adult zebrafish has been recently demonstrated50.
www.nature.com/scientificreports/
1 1Scientific REPORTs |  (2018) 8:7918  | DOI:10.1038/s41598-018-26343-2
The NTT, used to assess locomotor activity and anxiety, was performed using an experimental setup allowing 
monitoring and recording 2 fish simultaneously. The NTT was performed in two experimental tanks (20 cm 
length, 20 cm width, 25 cm height) containing 7 L (20 cm height) fish water at 28 °C. LED backlight illumination 
(GP-G2, Quirumed, Spain) located behind the tank provided uniform illumination for video-recording. Control 
and ACR-exposed fish were tested in the standard 6-min NTT. Each trial was video-recorded (AVI format, 30 
fps) with the uEye Cockpit software (version 4.90; Imaging Development Systems, Germany) controlling a GigE 
camera (UI-5240CP-NIR-GL, Imaging Development Systems, Germany) mounted in front of the experimental 
tank. In order to avoid any potential tank effect, experimental group assigned to each tank was switched between 
trials. After the recording was complete, the videos were analyzed by Ethovision XT 13.0 (Noldus, Wageningen, 
the Netherlands). First of all, the front of the tank was divided into two equal virtual zones, top and bottom 
(Fig. 1). Then, the total distance travelled (cm), distance travelled in the top and in the bottom (cm), latency to top 
(s), transitions to top, time spent in the top (s) and mobility state duration (s) were determined. Moreover, erratic 
movements as well as number and duration (s) of freezing bouts were manually recorded by trained observ-
ers, and ethograms were constructed in order to visualize the occurrence of these behaviors and the transitions 
between them, with the diameter of each circle reflecting the frequency of the behavioral activity, and the width 
and direction of each arrow representing the frequency of the transitions between behaviors23.
The zebrafish OFT was performed according to Gómez-Canela et al.51, with minor modifications. An exper-
imental setup for monitoring and recording 2 fish simultaneously was used. The OFT was performed in circular 
trunked conical white plastic tanks (testing tanks; 22.5 cm lower diameter × 25.0 cm upper diameter × 26.0 cm 
height) containing 5 L of fish water at 28 °C. The first 6 min of the trial were video-recorded (AVI format, 30 fps) 
with the uEye Cockpit software (version 4.90; Imaging Development Systems, Germany) controlling the GigE 
cameras (UI-5240CP-NIR-GL, Imaging Development Systems, Germany) placed on top of the testing tanks. Two 
anti-flicker LED tubes (TUT8-ST28-NFL; AS de LED®, Valencia, Spain) mounted on both sides of the test tanks 
provided uniform illumination for video-recording. In order to avoid any potential tank effect, experimental 
group assigned to each tank was switched between trials. The recorded videos were analyzed by Ethovision XT 
13.0, and the total distance travelled (cm), distance traveled in the periphery and the center (cm), time spent 
in the periphery and the center (s), mobility state, meandering (deg/cm), turn angle (deg) and angular velocity 
(deg/s) were determined. Moreover, the potential tight circling behavior was also analysed49 by a trained observer, 
recording the prevalence (%) of this behavior in each experimental group, the number of fish exhibiting “high 
rotation” (5 or more full rotation per trial), right-handed rotations and left-handed rotations.
The shoaling behavior was measured using the shoaling test, that consists in placing a group of fish into a novel 
tank and quantifying their spatial behavior and movement patterns52. For the shoaling test, groups of 6 zebrafish 
from the control and ACR groups were video-recorded for 6 min in our novel tank (Fig. 3), and analyzed using 
10 screenshots made every 20 s during the last half of the observation period. A total of 30 screenshots per exper-
imental group were used for analysis in this study. For each screenshot, distance between each fish in the group 
was measured by using the free-processing ImageJ software (National Institutes of Health (NIH), http://rsb.info.
nih.gov/ij/). Finally, the average interfish distance (cm), farthest neighbor distance (cm) and nearest neighbor 
distance (cm) were calculated23,33.
Whole-body cortisol assay. The cortisol extraction in whole body of adult zebrafish was performed using a 
modified protocol developed by Cachat et al.29. Briefly, the head from control and exposed zebrafish was removed 
before measuring the weight of each fish. Individual samples were then homogenized in 1 mL of ice-cold 1 × PBS 
buffer. Samples were transferred to glass extract-O tubes and cortisol was extracted twice with 5 mL of diethyl 
ether (Sigma-Aldrich, USA). After adding the ether, samples were vortexed and then centrifuged at 5000 rpm for 
15 minutes at room temperature. The top organic layer containing cortisol was collected into another glass tube 
and the process was repeated once more. The ether was left overnight under a fume hood to evaporate. Cortisol 
was then reconstituted in 1 mL of 1 × PBS and left to incubate overnight at 4 °C. For quantification of the cortisol 
levels, a human salivary cortisol ELISA kit (Salimetrics LLC, State College, PA) was used29,30. ELISA plate was 
measured in a Synergy 2 Multi-Mode Microplate Reader (BioTek Instruments – Vermont, USA). Whole-body 
cortisol levels in samples were determined, according to the manufacture, using a 4-parameter non-linear regres-
sion curve fit based on the absorbances of standardized concentrations, and reported as relative concentrations, 
ng g−1 of body weight for each fish.
Skin coloration. Changes in the skin coloration in response to ACR exposure were evaluated following 
standard protocols23,53. Briefly, we employed a standardized color rating scale (1 = pale body color; 2 = dark body 
color) assessed visually by 3 highly-trained observers (blinded to the treatments). Coloration of adult zebrafish 
control (n = 18) and exposed to 0.75 mM ACR for 3 days (n = 16) was recorded, and the decision for each animal 
was based on consensus among all observers.
RNA preparation and qRT-PCR analysis. Total RNA was extracted from the control (n = 17) and 
ACR-treated (n = 14) zebrafish brains and the expression of the nine selected genes (gap43, gfap, mbp, nsfa, 
tuba1b, syn2a, syt1a, sytxbp1b, c-fos) was determined by Real Time PCR, following standard protocols15 (see 
Supplementary Methods for additional details).
Proteomic Analysis. Protein fraction were extracted from pools of 3 brains from control and ACR-treated 
adult zebrafish (5 pools/group), trypsinized and analyzed by LC-MS/MS using a Q-Exactive-Plus mass spec-
trometer fitted with a capillary HPLC, following standard protocols (see Supplementary Methods for additional 
details).
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Proteomic data Analysis. The mass spectrometry data were analyzed using the MaxQuant software 1.5.2.8 
(www.maxquant.org)54 fitted with the Andromeda search engine55, searching against the Danio rerio Uniprot 
database (of March 2017 containing 59,064 entries) with mass tolerance of 20 ppm for the precursor masses and 
the fragment ions. Oxidation on methionine, propionamide on cysteine, histidine and lysine were accepted as 
variable modifications and carbamidomethyl on cysteine was accepted as fixed modifications. Minimal peptide 
length was set to six amino acids and a maximum of two miscleavages was allowed. Peptide and protein level 
false discovery rates (FDRs) were filtered to 1% using the target-decoy strategy. The identified protein table was 
filtered to remove the identifications from the reverse database, the common contaminants and single peptide 
identifications.
Data were quantified by normalized label free analysis using the same MaxQuant software (LFQ intensities), 
based on extracted ion currents (XICs) of peptides enabling quantitation from each LC/MS run for each peptide 
identified in any experiment.
Statistical analysis of the identification and quantitation results was performed using Perseus software 
1.5.1.656. Student’s T-test was done with 0.05 FDR and 250 randomizations. Proteins with P value less than 0.05 
and a difference of at least 2 fold between groups were labeled as differential.
Analysis of neurochemicals by LC-MS/MS. Individual zebrafish adult brain were extracted using a 
previous published method12. In the present study, 38 neurochemicals, including neurotransmitters, precur-
sors, metabolites and neuromodulators were determined by liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) using a Synergi Polar-RP 80 Å column (250 mm × 4.6 mm i.d., particle size 4 μM, 
Phenomenex, Torrance, USA; see Supplementary Methods for additional details).
Data analysis. Data were analyzed with IBM SPSS 19.0 (Statistical Package 2010, Chicago, IL), using 
chi-square test, Student’s t-test or one-way ANOVA followed by Dunnett’s multiple comparison test. Data are 
presented as the mean ± SEM of 2–3 independent experiments, unless otherwise stated. Significance was set at 
P < 0.05. Analysis of the qRT-PCR data, which was normally distributed (Levene’s test), was performed using the 
ΔΔCt method. Differences between the control and treated groups were analyzed by Student’s t-test.
Partial least squares-discriminant analysis (PLS-DA) were performed to determine the predictive capacity 
of combined behavior and chemical analysis data for discriminating between control and treated samples, using 
the package “mixOmics” in the “R” environment57. Missing values (less than 5%) were replaced by averaged 
values for each variable; untransformed values were used for all the analyses. Variables Important for Projection 
(VIPs) and PLS-DA performance (multiple-fold cross-validation, or Mfold) were calculated using the package 
“RVAideMemoire”, also in R.
Data availability. The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE partner repository with the dataset identifier PXD008993. The authors declare that 
all other data supporting the findings of this study are available within the manuscript and its Supplementary 
Information files, or are available from the corresponding author upon request.
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